Multiple Myeloma

Institute Will Offer Focused Treatment For Rare Cancer Form

Published in Blood Weekly, October 4th, 2001

The University of Arkansas for Medical Sciences (UAMS) has announced plans to build the world's first institute entirely dedicated to the research and treatment of multiple myeloma, a rare form of cancer affecting blood cells of the bone marrow.

UAMS's Myeloma Institute for Research and Therapy will focus exclusively on pioneering research and developing innovative treatment. "This unique institute will provide advanced medical training for oncologists with a specialization in multiple myeloma, conduct pioneering research in this field, and offer state-of-the-art treatment for patients from around the world," said Dodd Wilson, MD, UAMS Chancellor.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-10-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry